Back to Search
KUAN-YU CHI, M.D.
M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1689365926Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer.
PMID 19633045·Ann Oncol·2010
3-trial
Construction of and electrophoretic fluorescence imaging with a nano-porous polyaniline-fluorescein conducting particle system.
PMID 19294249·Chem Commun (Camb)·2009
8-other
Historical trends of dioxin-like compounds and heavy metals in sediments buried in a reservoir in central Taiwan.
PMID 19401259·Chemosphere·2009
8-other
Reactive oxygen species are involved in FasL-induced caspase-independent cell death and inflammatory responses.
PMID 19111607·Free Radic Biol Med·2009
7-preclinical
Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer.
PMID 18508203·Int J Radiat Oncol Biol Phys·2009
3-trial
Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.
PMID 19560857·Eur Urol·2009
6-review
Synthesis and characterisation of heterometallic molecular triangles using ambidentate linker: self-selection of a single linkage isomer.
PMID 19421624·Dalton Trans·2009
8-other
A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer.
PMID 19127560·Cancer·2009
4-observational
Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors.
PMID 19147776·Clin Cancer Res·2009
3-trial
Defining the optimal treatment strategy for localized prostate cancer patients: a survey of ongoing studies at the National Cancer Institute of Canada Clinical Trials Group.
PMID 18769611·Curr Oncol·2008
8-other
Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer.
PMID 19012510·Expert Opin Investig Drugs·2008
6-review
15-deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription.
PMID 18852146·Mol Cancer Ther·2008
8-other
Self-selection in the self-assembly of isomeric supramolecular squares from unsymmetrical bis(4-pyridyl)acetylene ligands.
PMID 18683976·J Org Chem·2008
8-other
Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis.
PMID 19043254·Intern Med·2008
5-case
PCDD/F adsorption and destruction in the flue gas streams of MWI and MSP via Cu and Fe catalysts supported on carbon.
PMID 18754500·Environ Sci Technol·2008
8-other
Innovative PCDD/F-containing gas stream generating system applied in catalytic decomposition of gaseous dioxins over V2O5-WO3/TiO2-based catalysts.
PMID 18752829·Chemosphere·2008
8-other
Unusually stable, versatile, and pure arenediazonium tosylates: their preparation, structures, and synthetic applicability.
PMID 18722457·Org Lett·2008
8-other
Systemic therapy after first-line docetaxel in metastatic castration-resistant prostate cancer.
PMID 18685415·Curr Opin Support Palliat Care·2008
6-review
Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo.
PMID 18814280·Int J Cancer·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- JACOBI MEDICAL CENTER, 1400 PELHAM PKWY SOUTH
NEW YORK, NY 10461 - Phone
- (718) 918-5640
Quick Facts
- NPI
- 1689365926
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile